New program aims to catch complications early in multiple myeloma patients after transplant
NCT ID NCT05947136
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a program called PASCA that helps doctors detect and manage complications like high blood pressure, kidney failure, chronic pain, and fatigue in multiple myeloma patients after a stem cell transplant. About 204 adults aged 18 to 70 will be randomly assigned to either the PASCA program or standard care. The goal is to see if proactive screening and early referrals improve long-term health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PASCA program (behavioral intervention: screening and referral for complications)
What this could lead to
If successful, this program could help doctors catch and treat complications like high blood pressure, kidney problems, or fatigue earlier, improving quality of life for multiple myeloma patients after transplant.
What could go wrong
This is a Phase 3 trial, but it tests a care program, not a new drug. The benefit may be small, and results may not apply to all patients or hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CENTRE HOSPITALIER UNIVERSITAIRE de MONTPELLIER
RECRUITINGMontpellier, 34295, France
Contact Email: •••••@•••••
Contact
-
CH Annecy Genevois
RECRUITINGÉpagny, 74370, France
Contact
Contact Email: •••••@•••••
-
CHU La Tronche
RECRUITINGGrenoble, 38300, France
Contact
Contact Email: •••••@•••••
-
CHU de St-Etienne
RECRUITINGSaint-Etienne, France
Contact Email: •••••@•••••
Contact
-
Centre Léon Bérard
RECRUITINGLyon, 69373, France
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Le Centre Hôpitaux Nord-Ouest Villefranche-sur-Saône
RECRUITINGVillefranche-sur-Saône, 69655, France
Contact
Contact Email: •••••@•••••